|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | LXI联盟为成功测试制定新标准显示文摘 | Bob Rennard | 2006 | 今日电子2006，，5： | 3 |
| 2 | LXI测试系统中IEEE 1588的应用显示文摘LXI联盟是主要测试和测量厂商的一个组织,负责开拓基于LAN通信和融合IEEE1588的模块化、分布式的仪器体系结构。本文将概要说明与IEEE1588相关的LXI规范,以及如何在基于LXI测试和测量系统中用IEEE1588建立时基。 | Bob Rennard | 2009 | 国外电子测量技术2009，28，2： | 2 |
| 3 | LXI联盟为成功测试制定新标准显示文摘 | Bob Rennard | 2006 | 国外电子测量技术2006，25，6： | 2 |
| 4 | A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comprison 显示文摘 | Rennard S Bantje T Centanni S | 2008 | Respir Med2008，102，7： | 1 |
| 5 | Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD显示文摘 | R. Graham Barr Bartolome R. Celli David M. Mannino Thomas Petty Stephen I. Rennard Frank C. Sciurba James K. Stoller Byron M. Thomashow Gerard M. Turino | 2009 | The American Journal of Medicine2009，，4： | 1 |
| 6 | COPD as a lung disease with systemic consequences clinical impact,mechanisma,and potential for early intervention显示文摘 | Decramer M Rennard S Troosters T | 2008 | COPD2008，5，4： | 1 |
| 7 | Human alveolar macrophage growth factor for fibroblasts显示文摘 | Bitterman PB Rennard SI Crystal RG | 1982 | J Clin Invest1982，70，： | 1 |
| 8 | Cilomilast for COPD: results of a 6- month, placebo controlled study of a potent, selective inhibitor of phosphodiesterase 4 显示文摘 | RENNARD S I SCHACHTER N STREK M | 2006 | Chest2006，129，1： | 1 |
| 9 | COPD as a lung dis-ease with systemic consequences-clinical impact,mechanisms,andpotential for early intervention显示文摘 | Decramer M Rennard S Troosters T | 2008 | COPD2008，5，4： | 1 |
| 10 | Pathogenesis of COPD显示文摘 | Spurzem JR Rennard SI | 2005 | Semin Respir Crit CareMed2005，26，2： | 1 |
| 11 | COPD as a lung disease with systemic consequences-clinical impact,mecha- nisms, and potential for early intervention 显示文摘 | Decramer M Rennard S Troosters T | 2008 | COPD2008，5，4： | 1 |
| 12 | New understanding of pathogenesis and mechanisms can guide future therapy 显示文摘 | Stephen I Rennard D | 2002 | Postgraduate Medicine Minneapolis2002，6，111： | 1 |
| 13 | Inflammation in COPD:a link to systemic comorbidities显示文摘 | Rennard SI | 2007 | Eur Respir2007，16，： | 1 |
| 14 | Persistent systemic inflammation is associated with poor clinical outcomes in COPD : a novel phenotype显示文摘 | Agusti A Edwards LD Rennard SI | 2012 | PLoS One2012，7，37： | 1 |
| 15 | COPD :the dangerous underestimate of 15%显示文摘 | Rennard SI Vestbo J | 2006 | Laneet2006，367，9518： | 1 |
| 16 | Varenieline, an α4β2 nicotinic acetyleholine receptor partial agonist, vs sustainted-release bupropion and placebo for smoking cessation: a randomized controlled trial 显示文摘 | Gonzales D Rennard SI Nide M | 2006 | JAMA2006，296，： | 1 |
| 17 | Inflammation and repair processes in chronic obstructive pulmonary disease显示文摘 | Rennard SI | 1999 | Am J Respir Crit Care Med1999，160，52： | 1 |
| 18 | COPD as a lung disease with systemic consequences--clinical impact,mechanisms,and potential for early intervention显示文摘 | Decramer M Rennard S Troosters T | | 0，，： | 1 |
| 19 | Eficacy and safety of budesonide and formoterul in one pressurized metered, dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial显示文摘 | Tashkin DP Rennard SI Matin P | 2008 | Drugs2008，68，6： | 1 |
| 20 | Inflammation and repair processes in chronic obstructive pulmonary disease显示文摘 | Rennard SI | 1999 | Am J Respir Crit Care Med1999，160，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员